Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV

NCT03614702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: 1-dose cIPV + 2-doses bOPV (Candy)
BIOLOGICAL: 1-dose sIPV + 2-doses bOPV (Candy)
BIOLOGICAL: 2-doses cIPV + 1-dose bOPV (Candy)
BIOLOGICAL: 2-doses sIPV + 1-dose bOPV (Candy)
BIOLOGICAL: 2-doses cIPV + 1-dose tOPV (Candy)
BIOLOGICAL: 2-doses sIPV + 1-dose tOPV (Candy)
BIOLOGICAL: 1-dose cIPV + 2-doses bOPV (Liquid)
BIOLOGICAL: 1-dose sIPV + 2-doses bOPV (Liquid)
BIOLOGICAL: 2-doses cIPV + 1-dose bOPV (Liquid)
BIOLOGICAL: 2-doses sIPV + 1-dose bOPV (Liquid)
BIOLOGICAL: 2-doses cIPV + 1-dose tOPV (Liquid)
BIOLOGICAL: 2-doses sIPV + 1-dose tOPV (Liquid)

Sponsor

Institute of Medical Biology, Chinese Academy of Medical Sciences

Collaborators

[object Object]